The Sonic Fund II, L.P. Issues Statement to Adverum Stockholders
May 11 2021 - 3:15PM
Business Wire
The Sonic Fund II, L.P. (“Sonic”), which beneficially owns
approximately 6.8% of the outstanding common stock of Adverum
Biotechnologies, Inc. (NASDAQ: ADVM) (the “Company” or “Adverum”),
today issued the following statement regarding the Company’s
upcoming 2021 Annual Meeting of Stockholders (the “2021 Annual
Meeting”), which will be held on Wednesday, May 12, 2021.
“It has come to our attention that one or more Adverum
stockholders were left with the impression, following discussions
with Adverum’s representatives, that Adverum’s management is
prepared to resign if Sonic’s three nominees are elected to the
Board. Sonic believes that all stockholders are entitled to
discount that fear to zero unless Adverum makes public disclosure
to all stockholders addressing management’s actual plans. We remind
stockholders that Delaware law imposes fiduciary responsibilities
on corporate officers, and hope that stockholders will see through
any last-ditch tactic to thwart an improved Board. If elected, our
fully independent nominees are each committed to working
collaboratively and constructively with the rest of the Board and
management from day one – with the sole goals of maximizing
stockholder value and delivering critical patient care.”
For more information, please visit www.SaveAdverum.com.
VOTE ON THE GREEN PROXY CARD TODAY
If you have voted a white card from Adverum,
a later-dated Green card will revoke that vote
If you have any questions or require any assistance with your
vote, please contact Saratoga Proxy Consulting, LLC, which is
assisting us, at its address and toll-free number listed on the
following page. For more information, fellow stockholders can visit
our website at https://www.saveadverum.com/investor-materials.
If you have any questions
regarding your GREEN proxy card
or need assistance in voting your shares, please contact
Saratoga Proxy Consulting,
LLC
520 8th Avenue
New York, NY 10018
Stockholders may call
toll-free: (888) 368-0379
Banks and brokers call: (212)
257-1311
info@saratogaproxy.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210511006123/en/
Investors: Saratoga Proxy Consulting LLC John Ferguson /
Ann Marie Mellone 212-257-1311 jferguson@saratogaproxy.com /
amellone@saratogaproxy.com
Media: Sloane & Company Joe Germani / Sarah
Braunstein jgermani@sloanepr.com / sbraunstein@sloanepr.com
Adverum Biotechnologies (NASDAQ:ADVM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Adverum Biotechnologies (NASDAQ:ADVM)
Historical Stock Chart
From Apr 2023 to Apr 2024